Net Margin: PainReform Corp (PRFX)

painreform.com - graphic logo of issuer PRFX

PainReform Ltd. develops innovative solutions for long-term pain management following surgical interventions. Production is based on ESG principles, minimizing toxic waste and adhering to research ethics. However, a high dependency on a single drug creates significant risks while awaiting regulatory verdicts. The operating net sales margin demonstrates profit dynamics, where -17158.10 reflects the baseline level of the metric.

PainReform Corp (PRFX) Net Profit Rate: for the period 07/04/2022 - 11/19/2026

Analytical breakdowns for PainReform Corp (PRFX)

- share price and expert price forecast:
- company stock exchange capitalization indicators:
Comprehensive company analysis:PainReform Ltd.
Flagship merchandise of PainReform Limited

Professional managers utilize fundamental filters to assess the quality of capital within an asset. This metric determines the share of net profit in every dollar earned, reflecting the actual efficiency of the operating cycle. For PainReform Ltd. (PRFX), this indicator is critical when automating anesthetic filling lines, as robotization should reduce costs. Analyzing the revenue profitability level allows for the timely detection of imbalances between revenue growth and expenses.

Who PainReform Ltd. competes with

HLN: Net Sales Margin|Net Return on Sales KVUE|Net Margin veronapharma.com|Net Return on Sales MENS (Jyong Biotech Corp)|Net Margin Ligand (LGND)|Net Sales Margin amneal.com (AMRX)|Net Sales Margin PRGO (perrigo.com)|Alvotech SA (ALVO) - Net Margin|Liquidia Inc. - Net Sales Margin|Net Profitability Margin Galapagos Corp (GLPG)|ANI Pharmaceuticals (ANIP) - Net Margin|Net Return on Sales MNKD|Net Margin Amphastar Pharmaceuticals, Inc.|Pacira Pharmaceuticals (PCRX) - Company Sales Margin|Net Sales Margin SPRY|TBPH - Net Margin|Aquestive Pharma - Return on Sales by Net Profit|Net Sales Margin scpharmaceuticals.com SCPH|Tectonic - Net Sales Margin|TNXP - Net Sales Margin|SXTC: Net Sales Margin|Eupraxia Pharma - Net Profit Rate|BHST (bioharvest.com) - Net Sales Margin|Net Return on Sales EXOZ (invizyne.com)|Net Sales Margin ORMP|Company Sales Margin Entera Bio|Net Sales Margin HYFT (MindWalk Holdings, Inc.)|ABVC BioPharma - Net Margin|Cumberland Corp - Net Sales Margin|QNTM - Net Sales Margin|FibroGen, Inc. (FGEN) - Net Margin|TELO: Company Net Profitability|RANI (Rani Therapeutics Inc) - Net Sales Margin|Net Margin synergychc.com SNYR|Net Margin Rallybio Corp. (RLYB)|LEXX - Net Margin|Net Sales Margin PULM (pulmatrix.com)|Company Net Profitability PTHL (Pheton)|APM - Net Margin|Company Sales Margin Lyra Therapeutics Inc LYRA|impactbiomedinc.com (IBO) - Net Margin|TNF Pharma (TNFA) - Net Sales Margin|YCBD (cbdmd.com) - Net Sales Margin|CYTO (altamiratherapeutics.com) - Company Net Profitability|Net Sales Margin LIPO|OPTN - Net Margin|Net Margin pieris.com PIRS|Net Profit Rate PROC|PTPI - Net Margin|Qilian International Holding (QLI) - Return on Sales by Net Profit|SLRN: Net Sales Margin|Return on Sales by Net Profit TFF Pharma